Akari Therapeutics PLC
NASDAQ:AKTX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Akari Therapeutics PLC
NASDAQ:AKTX
|
US |
|
A
|
Aubay SA
XBER:BAQ
|
FR |
|
N
|
Netel Holding AB (publ)
STO:NETEL
|
SE |
|
A
|
ACC Aviation Holdings Ltd
OTC:CAVG
|
IL |
|
Conduit Holdings Ltd
OTC:CNDHF
|
BM |
|
C
|
Clean Motion AB
STO:CLEMO
|
SE |
|
Stratabound Minerals Corp
XTSX:SB
|
CA |
|
T
|
Tco Holdings JSC
VN:TCO
|
VN |
|
Oneview Healthcare PLC
OTC:ONVVF
|
IE |
|
M
|
Mercari Inc
TSE:4385
|
JP |
|
M
|
Mercari Inc
OTC:MCARY
|
JP |
|
Zoo Digital Group PLC
F:2ZD
|
UK |
|
P
|
Prosus NV
JSE:PRX
|
NL |
Bankruptcy Probability
Akari Therapeutics PLC's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Akari Therapeutics PLC Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Akari Therapeutics PLC
NASDAQ:AKTX
|
5.6m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
883.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
585.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
237.5B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
299.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
235.8B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
161B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
120B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Akari Therapeutics PLC's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Akari Therapeutics PLC has total debt of 2.1m USD. This includes both short-term (2.1m USD) and long-term (0 USD) debt.
You can find a full breakdown on its Balance Sheet.
